RG7713

CAS : 920022-47-5

Ref. 3D-VLB02247

Informations sur le produit

• Nom: RG7713
• CAS: 920022-47-5

Description

RG7713 is an investigational drug that belongs to the class of cytochrome P450 3A4 (CYP3A4) inhibitors. RG7713 inhibits CYP3A4 activity and has been shown to be a potent inhibitor of CYP3A4-mediated metabolism in vitro. It is also a potent inhibitor of the human recombinant CYP3A4 enzyme, inhibiting the metabolic conversion of many drugs, including neuroleptics, antidepressants, antipsychotics, anticonvulsants, beta-blockers, and calcium channel blockers. RG7713 has demonstrated efficacy in preclinical studies in mice and rats for its cognition-enhancing effects. The drug was well tolerated at doses up to 10 mg/kg/day for 28 days without any adverse effects on body weight or food intake. There are no clinical studies yet on RG7713's safety and efficacy for humans.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 437.96 g/mol
• Formule: C₂₅H₂₈ClN₃O₂
• Degré de pureté: Min. 95%